Ładuje się......
Noncytotoxic Pyrrolobenzodiazepine–Ciprofloxacin Conjugate with Activity against Mycobacterium tuberculosis
[Image: see text] The development of new antitubercular agents for the treatment of infections caused by multidrug-resistant (MDR) Mycobacterium tuberculosis is an urgent priority. Pyrrolobenzodiazepines (PBDs) are a promising class of antibacterial agents that were initially discovered and isolated...
Zapisane w:
| Wydane w: | ACS Omega |
|---|---|
| Główni autorzy: | , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Chemical Society
2019
|
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6921268/ https://ncbi.nlm.nih.gov/pubmed/31867477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.9b00834 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|